Post job

Emergent BioSolutions main competitors are Gilead Sciences, Sarepta Therapeutics, and Medivation.

Competitor Summary. See how Emergent BioSolutions compares to its main competitors:

  • Pfizer has the most employees (78,500).
  • Employees at Gilead Sciences earn more than most of the competitors, with an average yearly salary of $99,828.
  • The oldest company is Pfizer, founded in 1849.
Work at Emergent BioSolutions?
Share your experience

Emergent BioSolutions vs competitors

CompanyFounding dateZippia scoreHeadquarters# of LocationsRevenueEmployees
1998
4.8
Gaithersburg, MD12$1.6B1,834
1987
4.5
Foster City, CA9$28.8B11,800
1992
4.9
Rockville, MD1$131.0M1,000
1891
4.6
Kenilworth, NJ31$64.2B74,000
1987
4.4
Princeton, NJ25$2.6B50,000
1980
4.8
Cambridge, MA2$1.9B840
2002
4.4
Henderson, NV3$10.1M235
2003
4.8
San Francisco, CA1$1.0B628
2002
4.8
Cambridge, MA2$2.2B1,323
1849
4.5
New York, NY18$63.6B78,500
1963
4.3
Bloomington, IN1$2.0B12,000
1980
4.8
Thousand Oaks, CA9$33.4B22,000
1984
4.8
Bridgewater, NJ1$39.0M180
1987
4.7
Gaithersburg, MD1$422.2M6,030
2006
4.1
Lexington, MA2$7.2M182
1981
4.8
Cambridge, MA1$4.6B12,000
2000
3.9
Phoenix, AZ1$8.5M150
McNeil Consumer Healthcare
1879
4.3
Fort Washington, PA1$46.2M17
1988
4.9
Tarrytown, NY7$14.2B9,123
1987
4.9
Waltham, MA3$1.6B1,200
1991
4.7
Westlake Village, CA2$10.0M233

Emergent BioSolutions competitors jobs

Emergent BioSolutions jobs openings vs similar companies

If you’re looking for a job, here are the jobs openings at Emergent BioSolutions and its competitors.

Emergent BioSolutions remote jobs

Rate Emergent BioSolutions' competitiveness in the market.

Zippia waving zebra

Emergent BioSolutions salaries vs competitors

Among Emergent BioSolutions competitors, employees at Gilead Sciences earn the most with an average yearly salary of $99,828.

Compare Emergent BioSolutions salaries vs competitors

CompanyAverage salaryHourly salarySalary score
Emergent BioSolutions
$77,521$37.27-
Gilead Sciences
$99,828$47.99-
Human Genome Sciences
$70,157$33.73-
Merck
$90,328$43.43-
Covance
$64,568$31.04-
Sarepta Therapeutics
$94,985$45.67-

Compare Emergent BioSolutions job title salaries vs competitors

CompanyHighest salaryHourly salary
Emergent BioSolutions
$92,394$44.42
Sarepta Therapeutics
$89,829$43.19
Amgen
$89,140$42.86
McNeil Consumer Healthcare
$88,611$42.60
Regeneron
$86,501$41.59
Medimmune
$85,697$41.20
ImClone Systems LLC
$84,373$40.56
Sanofi Genzyme
$83,764$40.27
Human Genome Sciences
$80,605$38.75
Pfizer
$79,956$38.44
Merck
$79,936$38.43
Science Care
$79,768$38.35
Alkermes
$79,317$38.13
Alnylam Pharmaceuticals
$77,388$37.21
T2 Biosystems
$77,313$37.17
Medivation
$77,282$37.15
Cook Group
$76,167$36.62
Covance
$74,367$35.75
MannKind
$74,065$35.61
Gilead Sciences
$73,820$35.49

Do you work at Emergent BioSolutions?

Does Emergent BioSolutions effectively differentiate itself from competitors?

Emergent BioSolutions jobs

Emergent BioSolutions demographics vs competitors

Compare gender at Emergent BioSolutions vs competitors

Job titleMaleFemale
Alnylam Pharmaceuticals49%51%
MannKind53%47%
Merck54%46%
Emergent BioSolutions56%44%
Gilead Sciences56%44%
Amgen57%43%

Compare race at Emergent BioSolutions vs competitors

CompanyWhiteHispanic or LatinoBlack or African AmericanAsianUnknownDiversity score
60%11%16%9%4%
9.6
59%14%5%16%6%
9.1
49%24%7%15%5%
9.7
44%20%8%23%6%
9.8
57%17%10%12%4%
9.0
56%16%10%14%4%
9.8

Emergent BioSolutions revenue vs competitors

Emergent BioSolutions revenue is $1.6B. Among it's competitors, the company with the highest revenue is Merck, $64.2B . The company with the lowest revenue is T2 Biosystems, $7.2M.

Emergent BioSolutions and similar companies CEOs

CEOBio
Yvonne L. Greenstreet
Alnylam Pharmaceuticals

Yvonne Greenstreet is a COO at ALNYLAM PHARMACEUTICALS, INC..

Robert A. Bradway
Amgen

Robert A. Bradway is an American businessman. He is the chairman and chief executive officer of Amgen.

Daniel O’Day
Gilead Sciences

Michael E. Castagna
MannKind

Michael Castagna is a Board Member at MANNKIND CORP and Chief Executive Officer at MANNKIND CORP and is based in Westlake Village, California. He has worked as Vice President & Head, Biopharmaceuticals North America at Sandoz; Director, Endocrinology Marketing at Healthcare Business of Merck; and VP/Global Head:Commercial at Amgen. Michael attended Massachusetts College of Pharmacy and Health Sciences between 2012 and 2014, The Wharton School between 2003 and 2005, and Philadelphia College of Pharmacy & Science.

Robert M. Davis
Merck

Robert M. Davis is corporate vice president and president of Baxter's Medical Products business. In this position, Davis oversees a range of products used in the delivery of fluids and drugs to patients, and in the treatment of end-stage kidney disease. Davis took on his current role in October 2010. Prior to this role, Davis served as corporate vice president and president of Baxter's Renal business. He served as corporate vice president and chief financial officer from 2006 through May 2010, and as treasurer from 2004 through 2006. Davis joined Baxter as treasurer in November 2004 from Eli Lilly and Company, where he served in numerous positions of increasing responsibility over 14 years. Davis currently serves on the Board of Trustees for Rush University Medical Center and also serves as a member of the Finance Committee. He also is a member of the Board of Directors of AdvaMed.

Dr. Albert Bourla
Pfizer

Albert Bourla (Greek: Άλμπερτ Μπουρλά, born) is a Greek veterinarian and the chairman and chief executive officer of Pfizer, an American pharmaceutical company. He joined the company in 1993 and has held several executive roles across Pfizer's divisions. Prior to becoming chief executive officer, Bourla served as chief operating officer.

Douglas S. Ingram
Sarepta Therapeutics

Douglas 'Doug' Ingram is a CEO and President at SAREPTA THERAPEUTICS, INC.; Board Member at SAREPTA THERAPEUTICS, INC.; and Board Member at Relay Therapeutics Inc and is based in Irvine, California. He has worked as Assistant General Counsel at Actavis, President at Actavis, and Board Member at Volcom. Douglas works or has worked as BOARD MEMBER at Allergan Foundation and Board Member at Pacific Life. He studied at James E Rogers College of Law until 1988, Arizona State University between 1980 and 1985, and University of Arizona.

Joseph W. Turgeon
Spectrum Pharmaceuticals

Joe Turgeon is a President, COO at SPECTRUM PHARMACEUTICALS INC.

John J. Sperzel
T2 Biosystems

CEO at T2 Biosystems | Board Member | Heart Transplant Recipient | Sepsis Survivor | Best Selling Author | Inspirational Speaker

Carl Cook
Cook Group

Emergent BioSolutions competitors FAQs

Search for jobs